Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Sean Scanlan Biography and Net Worth

SVP of Treace Medical Concepts

Sean F. Scanlan, PhD has over 14 years of orthopaedic research and product development experience. Mr. Scanlan has served as our Senior Vice President, Marketing & Medical Education since March 2021 and before that as our Vice President, Marketing & Medical Education since January 2018, after serving in various marketing roles of increasing responsibility since December 2014. Prior to joining our company, Mr. Scanlan spent 3 years in Research & Development at Smith & Nephew’s Advanced Surgical Devices division focused on product development and early-stage technology assessment. Before that, he led an interdisciplinary clinical research study at Stanford University with the Orthopaedic Surgery and Engineering departments, focusing on orthopaedic surgery and engineering, and served as a consultant for an early-stage orthopaedics start-up company, Moximed, Inc. Mr. Scanlan holds a B.S. in Engineering Science (Biomechanics) from the University of Florida, and an M.S. and PhD in Mechanical Engineering (Biomechanical Engineering division) from Stanford University.

What is Sean F. Scanlan's net worth?: The estimated net worth of Sean F. Scanlan is at least $225,469.20 as of May 16th, 2023. Dr. Scanlan owns 32,395 shares of Treace Medical Concepts stock worth more than $225,469 as of December 21st. This net worth evaluation does not reflect any other investments that Dr. Scanlan may own. Learn More about Sean F. Scanlan's net worth.
How old is Sean F. Scanlan?: Dr. Scanlan is currently 42 years old. There are 7 older executives and no younger executives at Treace Medical Concepts. The oldest executive at Treace Medical Concepts is Ms. Julie D. Dewey, Chief Communications & Investor Relations Officer, who is 63 years old. Learn More on Sean F. Scanlan's age.
How do I contact Sean F. Scanlan?: The corporate mailing address for Dr. Scanlan and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]. Learn More on Sean F. Scanlan's contact information.
Has Sean F. Scanlan been buying or selling shares of Treace Medical Concepts?: Sean F. Scanlan has not been actively trading shares of Treace Medical Concepts during the last quarter. Most recently, Sean F. Scanlan sold 25,000 shares of the business's stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $25.44, for a transaction totalling $636,000.00. Following the completion of the sale, the insider now directly owns 32,395 shares of the company's stock, valued at $824,128.80. Learn More on Sean F. Scanlan's trading history.
Who are Treace Medical Concepts' active insiders?: Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.
Are insiders buying or selling shares of Treace Medical Concepts?: During the last twelve months, Treace Medical Concepts insiders bought shares 12 times. They purchased a total of 812,902 shares worth more than $4,206,561.76. The most recent insider tranaction occured on September, 16th when CEO John T Treace bought 50,000 shares worth more than $265,500.00. Insiders at Treace Medical Concepts own 24.4% of the company. Learn More about insider trades at Treace Medical Concepts.
Information on this page was last updated on 9/16/2024.

Sean F. Scanlan Insider Trading History at Treace Medical Concepts

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2023	Sell	25,000	$25.44	$636,000.00	32,395
2/15/2023	Sell	25,000	$21.69	$542,250.00	9,975
1/12/2023	Sell	25,000	$25.57	$639,250.00	9,975
11/14/2022	Sell	25,000	$24.27	$606,750.00	9,975
3/2/2022	Sell	25,000	$20.82	$520,500.00
2/9/2022	Sell	3,873	$20.16	$78,079.68
1/10/2022	Sell	38,862	$20.16	$783,457.92
1/5/2022	Sell	800	$20.02	$16,016.00
1/3/2022	Sell	1,000	$20.02	$20,020.00
11/10/2021	Sell	25,000	$21.54	$538,500.00

Sean F. Scanlan Buying and Selling Activity at Treace Medical Concepts

Treace Medical Concepts Company Overview

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Today's Range

Now: $6.96

$6.77

$7.11

50 Day Range

MA: $6.94

$4.66

$8.78

2 Week Range

Now: $6.96

$3.92

$15.98

Volume

319,051 shs

Average Volume

783,198 shs

Market Capitalization

$433.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66

First JFK… next Elon?

From Porter & Company | Ad